A. M. Lone et al. / Tetrahedron Letters xxx (2014) xxx–xxx
3
NMR (400 MHz, CDCl3) d 7.76–7.59 (4H, m), 7.51–7.48 (6H, m), 4.26 (1H, m),
4.09 (2H, m), 2.49 (2H, m), 1.48 (2H, m), 1.27–1.10 (7H, m), 1.09 (9H, s), 0.78
(3H, t, J = 8 Hz); 13C NMR (100 MHz, CDCl3) d 171.6, 135.9, 134.1, 129.5, 127.4,
70.5, 60.2, 42.1, 36.7, 26.9, 26.8, 22.4, 19.3, 14.1, 13.9; HRMS (ES) m/z calcd for
In conclusion, we have developed an exceptionally simple and
practical protocol for the synthesis of Hagen’s gland lactones 1
and 2 from cheap, commercially available pentanal and heptanal,
respectively, in six steps involving ring closing-metathesis and
oxy-Michael addition as the key operations.
C
25H36O3Si [M]+: 412.2434; found: 412.2431; Compound 10: IR (CHCl3) 3023,
2926, 2857, 2839, 1739, 1312, 1192, 1021, 925 cmÀ1 1H NMR (400 MHz, CDCl3)
;
d 9.69 (1H, s), 7.69–7.63 (4H, m), 7.49–7.31 (6H, m), 4.25 (1H, m), 2.48 (2H, m),
1.61–1.39 (2H, m), 1.27–1.12 (4H, m), 1.06 (9H, s), 0.79 (3H, t, J = 8 Hz,); 13C
NMR (100 MHz, CDCl3) d 202.4, 135.9, 135.8, 133.9, 133.6, 129.8, 129.7, 127.7,
127.6, 69.3, 50.1, 37.0, 31.9, 27.0, 22.4, 19.3, 13.9; HRMS (ES) m/z calcd for
Acknowledgments
C
23H32O2Si [M+H]+: 369.2172; found: 369.2248; Compound 1: IR (CHCl3) 3016,
2861, 2929, 2858, 1781, 1648, 1471, 1340, 1183, 1062, 908 cmÀ1 1H NMR
;
B.A.B. acknowledges the financial support from the Department
of Science and Technology, India (GAP 1199) and A.M.L. thanks
University Grants Commission, India for the award of senior
research fellowship. We are also highly grateful to the Director
IIIM, Dr. Ram Vishwakarma, for his generous support to setup syn-
thetic chemistry facilities in the Srinagar campus of IIIM.
(400 MHz, CDCl3) d 5.11 (1H, t, J = 4.7 Hz), 4.80 (1H, dt, J = 6.7, 5.1 Hz), 4.09– 4.02
(1H, m), 2.74 (1H, dd, J = 18.8, 6.7 Hz), 2.61 (1H, d, J = 18.8 Hz), 2.35 (1H, dd,
J = 14.0, 4.7 Hz), 1.69–1.58 (2H, m), 1.55–1.48 (1H, m), 1.38–1.21 (4H, m), 0.89
(3H, t, J = 7.2 Hz); 13C NMR (100 MHz, CDCl3) d 175.9, 84.6, 78.0, 77.1, 38.5, 36.3,
34.0, 28.2, 22.3, 13.7; HRMS (ES) m/z calcd for C10H16O3 [M+H]+: 185.1099;
found: 185.1175; Compound 14: IR (CHCl3) 3013, 2958, 2936, 2855, 1773, 1642,
1457, 1353, 1180, 1068, 967, 904, 852 cmÀ1 1H NMR (400 MHz, CDCl3) d 5.01
;
(1H, ddd, J = 6.8, 4.3, 2.2 Hz), 4.49 (1H, dd, J = 7.2, 3.4 Hz), 3.95–3.93 (1H, m),
2.70 (2H, d, J = 3.2 Hz), 2.40 (1H, ddd, J = 14.0, 7.6, 6.5 Hz), 1.87 (1H, ddd, J = 14.0,
7.8, 2.1 Hz), 1.67–1.63 (1H, m), 1.58–1.49 (1H, m,), 1.40–1.20 (4H, m), 0.89 (3H,
t, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3) d 175.5, 84.5, 80.0, 78.0, 38.0, 36.2, 35.1,
28.0, 22.3, 13.9; HRMS (ES) m/z calcd for C10H16O3 [M+H]+: 185.1099; found:
185.1175; Compound 16: IR (CHCl3) 3039, 2864, 2928, 2849, 1745, 1637, 1335,
References and notes
1139, 1104, 9013 cmÀ1 1H NMR (400 MHz, CDCl3) d 7.79–7.68 (4H, m), 7.44–
;
7.41 (6H, m), 4.22 (1H, m), 4.05 (2H, m), 2.48 (2H, m), 1.22–1.123 (13H, m), 1.06
(9H, s), 0.86 (3H, t, J = 7.8 Hz); 13C NMR (100 MHz, CDCl3) d 171.6, 135.9, 134.3,
129.9, 127.6, 70.5, 60.2, 42.1, 36.7, 26.9, 26.8, 22.4, 19.3, 14.1,13.9; HRMS (ES) m/
z calcd for C27H40O3Si [M]+: 440.2747; found: 440.2743; Compound 17: IR
(CHCl3) 3021, 2931, 2862, 2843, 1736, 1315, 1187, 1018, 919 cmÀ1 1H NMR
;
(400 MHz, CDCl3) d 9.75 (1H, s), 7.71–7.68 (4H, m), 7.46–7.40 (6H, m), 4.23 (1H,
m), 2.51 (2H, m), 1.62–1.13 (10H, m), 1.04 (9H, s), 0.86 (3H, t, J = 8 Hz); 13C NMR
(100 MHz, CDCl3) d 202.4. 135.8, 135.7, 133.9, 133.7, 129.8, 129.7, 127.7, 127.5,
69.3, 50.1, 37.0, 31.6, 29.6, 26.9, 24.4, 22.4, 19.3, 13.9; HRMS (ES) m/z calcd for
C
25H36O2Si [M+H]+: 397.2485; found: 397.2561; Compound 2: IR (CHCl3) 3018,
2934, 2861, 1775, 1467, 1337, 1168, 1069, 913 cmÀ1 1H NMR (400 MHz, CDCl3)
;
d 5.09 (1H, t, J = 4.5 Hz), 4.80 (1H, t, J = 5.5 Hz), 4.08–4.01 (1H, m), 2.73 (1H, dd,
J = 18.7, 6.4 Hz), 2.62 (1H, d, J = 18.5 Hz), 2.36 (1H, dd, J = 14.0, 4.8 Hz), 1.68–1.55
(1H, m), 1.52À 1.25 (10H, m), 0.87 (3H, t, J = 7.0 Hz); 13C NMR (100 MHz, CDCl3)
d 175.9, 84.7, 78.1, 77.1, 38.6, 36.5, 34.5, 31.4, 29.3, 25.9, 22.4, 13.9; HRMS (ES)
m/z calcd for C12H20O3 [M+H]: 213.1412; found: 213.1487; Compound 21: IR
(CHCl3) 3012, 2931, 2864, 1777, 1638, 1467, 1414, 1347, 1201, 1161, 1082,
903 cmÀ1 1H NMR (400 MHz, CDCl3) d 5.01 (1H, ddd, J = 7.0, 4.5, 2.3 Hz), 4.49
;
(1H, dd, J = 7.0, 3.5 Hz), 3.95–3.89 (1H, m), 2.72 (2H, d, J = 3.5 Hz), 2.40 (1H, ddd,
m, J = 14.0, 7.0, 6.5 Hz), 1.86 (1H, ddd, J = 14.1, 7.8, 2.1 Hz), 1.64–1.59 (1H, m),
1.56–1.53 (1H, m), 1.40–1.26 (8H, m), 0.89 (3H, t, J = 7.1 Hz); 13C NMR (100 MHz,
CDCl3) d 175.5, 84.4, 80.1, 78.3, 38.1, 36.2, 35.3, 31.5, 29.3, 26.2, 22.4, 14.0;
HRMS (ES) m/z calcd for C12H20O3 [M+H]: 213.1456; found: 213.1487.
6. All compounds reported were fully characterized on the basis of IR, 1H NMR, 13
C
NMR, and HRMS data. Spectral data of selected compounds: Compound 9: IR
(CHCl3) 3045, 2863, 2932, 2853, 1748, 1643, 1334, 1133, 1095, 905 cmÀ1 1H
;